Stay updated on BAT2206 vs Stelara in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the BAT2206 vs Stelara in Psoriasis Clinical Trial page.

Latest updates to the BAT2206 vs Stelara in Psoriasis Clinical Trial page
- Check4 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No other study details or sections appear to have changed.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now displays Revision: v3.4.1 (replacing Revision: v3.4.0), a minor site maintenance update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedFooter metadata updates include 'Last Update Submitted That Met QC Criteria', 'Revision: v3.4.0', and 'No FEAR Act Data', plus a new 'Show glossary' option. The previous labels and capitalization (e.g., 'Last Update Submitted that met QC Criteria', 'No FEAR Act data') were removed or changed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated to v3.3.4, replacing the previous v3.3.3.SummaryDifference0.1%

- Check76 days agoChange DetectedLocations section updated to include Zhejiang as a study location, and Zhejiang Locations in the footer removed; the page revision updated to v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

Stay in the know with updates to BAT2206 vs Stelara in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BAT2206 vs Stelara in Psoriasis Clinical Trial page.